AstraZeneca has reported record second quarter revenues, propelled by robust oncology sales and expansion in the United States, surpassing City expectations. The pharmaceutical company’s total revenue rose by 11 per
All posts tagged in oncololgy
1Article
- Home
- oncololgy
Recent Posts
- Denmark’s Pharmaceutical Giant Faces Economic Challenges
- John Lewis Plans To Buy Back Waitrose Supermarkets
- OpenAI Achieves Record Valuation After Major Funding Round
- Advent International Considering Bid for Senior Engineering Group
- Donald Trump Orders Ban on Anthropic Technology Amidst Controversy
- Jim Ratcliffe invests in Ineos Project One chemicals plant despite significant market challenges
- International Airlines Group reports strong financial results and plans significant share buyback
- Heathrow Airport Third Runway Estimated Cost Nears One Million Pounds Per Metre
- Barclays Faces Scrutiny After MultiMillion Pound Exposure to Loan Provider
- Collapse of Mortgage Lender Unveils Significant Financial Risks
- Rachel Reeves set to collect £40 billion in student loan interest
- Tyrrells Ends Non Potato Vegetable Crisps Range
- Rightmove shares rise as AI threat downplayed
- Paramount Wins Battle for Warner Bros Discovery
- FTSE 100 Marks Record Gains in February
- Trump tariffs push UK businesses closer to China
- Ed Miliband Opens Door to Increased Chinese Investment in UK Energy Sector
- UK Ministry of Defence Approves £1 Billion Helicopter Contract
- Anthropic Seeks to Position Claude as Core Enterprise Infrastructure Rather Than Standalone Tool
- Netflix Walks Away from Warner Bros Bid as Paramount Offers Superior Deal
- Cindy Rose Unveils Strategy to Overhaul WPP
- OpenAI Expands Research Presence in London Amid AI Talent Competition
- Lloyds Banking Group Halts In-Branch Account Openings
- Anthropic Chief Executive Declines Pentagon Request to Remove Artificial Intelligence Safety Protocols
- Ocado Confirms 1000 Job Cuts Amid Cost Reduction Strategy
- Vauxhall Owner Stellantis Reports €22 Billion Loss
- London Stock Exchange CEO Rejects AI Threat Claims
- Rolls Royce share buyback sees profits soar
- Aria Launches £50 Million AI Chip Testbed Facility
- Hikma Pharmaceuticals Shares Drop Amid Weaker Forecasts and Leadership Changes
